Cultures Magazine Launch Event - MWV84

submitted by: MicrobeWorld

Watch highlights from the Cultures Magazine Launch Event held on January 23, 2014 at American Society for Microbiology headquarters in Washington, D.C.

Cultures is a free, online, open-source publication available for viewing at www.asm.org/cultures.

Novel cell-based and materials science approach to target Glioblastoma brain cancer tumors

submitted by: nsf

Stefan Bossmann and Deryl Troyer at Kansas State University are developing a novel materials treatment method for persons with brain cancer that uses a type of white blood cell to deliver anticancer drugs to particularly virulent brain tumors.

Silencing the Menkes Copper-Transporting ATPase (Atp7a) Gene in Rat Intestinal Epithelial (IEC-6) Cells Increases Iron Flux via Transcriptional Induction of Ferroportin 1 (Fpn1)

submitted by: jfcollins
The Menkes copper-transporting ATPase (Atp7a) gene is induced in rat duodenum during iron deficiency, consistent with copper accumulation in the intestinal mucosa and liver. To test the hypothesis that ATP7A influences intestinal iron metabolism, the Atp7a gene was silenced in rat intestinal epithelial (IEC-6) cells using short hairpin RNA (shRNA) technology. Perturbations in intracellular copper homeostasis were noted in knockdown cells, consistent with the dual roles of ATP7A in pumping...
Authors: Sukru Gulec, James F. Collins

20131022 - Protein Prediction 2 - Burkhard Rost - Individual Health

submitted by: rostlab

Date: 20131022

Course: Protein Prediction 2

Title: Individual Health

Speaker: Burkhard Rost

Audience: Computer Science students

20131022 - Protein Prediction 2 - Burkhard Rost - Individual Health

submitted by: rostlab

Date: 20131022

Course: Protein Prediction 2

Title: Individual Health

Speaker: Burkhard Rost

Audience: Computational Biology students

MWV Episode 76 - Jeffrey Almond - Vaccine Development

submitted by: MicrobeWorld
Dr. Jeffrey Almond began his career as an academic virologist studying influenza. Eventually Jeffrey started his own lab and began studying picornaviruses working on an oral polio vaccine strain. Following twenty years in academics including major contributions in the eradication of polio worldwide, Jeffrey transitioned into a career in industry working on vaccine development at Sanofi Pasteur. In March of 2013, Jeffrey was at the Society for General Microbiology's Spring conference to...